ZIOPHARM Oncology Inc (ZIOP) Declined -18.37% or -0.79 To Price $3.51 On Monday


ZIOPHARM Oncology Inc (ZIOP) declined -18.37% or -0.79 to $3.51. It is approximately 4.95 million shares traded, which is 435.57% compare to the average total volume 1.14 million. The market cap of ZIOP is $499.82 million. The year to date change is -21.53%. The 52 week price range is from $3.33 to $6.67. Price of ZIOP have changed -1.60% during last week. It have changed -4.87% over last month, -1.60% over last 3 months, -1.15% over last 6 months and -20.96% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZIOP is 4.43. It is 26.21% above current price. The 200-day Moving Averages for ZIOP is 4.66. It is 32.76% above current price. The 52-week High is 6.67. It is 90.03% from the current price. The 52-week Low is 3.33. It is -5.13% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZIOP is 33.98 on 2018-05-31. Short % to float is 24.92%. There are some statistics of ZIOP. It is has market cap $499.82 million. The share outstanding is 142.40 million. The average volume is 1.14 million. The revenue is 3.20M. The percent of top 15 Institution holding is 38.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZIOP is 68.56%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZIOP is -82.16%.


Tags:

Share this post